Steven W. King

2016

In 2016, Steven W. King earned a total compensation of $1.2M as Former President and Chief Executive Officer at Peregrine Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$362,000
Option Awards$316,860
Salary$520,000
Other$51,043
Total$1,249,903

King received $520K in salary, accounting for 42% of the total pay in 2016.

King also received $362K in non-equity incentive plan, $316.9K in option awards and $51K in other compensation.

Rankings

In 2016, Steven W. King's compensation ranked 7,187th out of 14,075 executives tracked by ExecPay. In other words, King earned more than 48.9% of executives.

ClassificationRankingPercentile
All
7,187
out of 14,075
49th
Division
Manufacturing
2,708
out of 5,489
51st
Major group
Chemicals And Allied Products
887
out of 1,895
53rd
Industry group
Drugs
687
out of 1,538
55th
Industry
Pharmaceutical Preparations
546
out of 1,176
54th
Source: SEC filing on August 17, 2018.

King's colleagues

We found three more compensation records of executives who worked with Steven W. King at Peregrine Pharmaceuticals in 2016.

2016

Paul Lytle

Peregrine Pharmaceuticals

Chief Financial Officer

2016

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

2016

Joseph Shan

Peregrine Pharmaceuticals

Former Vice President, Clinical & Regulatory Affairs

News

You may also like